Rockville-based Emergent BioSolutions Inc. has formed a public-private partnership with the Department of Health and Human Services to establish a Center for Innovation in Advanced Development and Manufacturing.
The contract has an initial run of eight years worth $220 million with up to 17 additional one-year options. The partnership, with HHS’s Biomedial Advanced Research and Development Authority, will initially develop a new pandemic influenza vaccine and construct facilities to produce it.
To read the full, original article click on this link: Emergent BioSolutions to develop HHS innovation center – Washington Business Journal
{iframe}http://www.bizjournals.com/washington/news/2012/06/18/emergent-to-develop-hhs-innovation.html?ana=e_wash_rdup&s=newsletter&ed=2012-06-19{/iframe}